Literature DB >> 25498723

Inulin crystal initiation via a glucose-fructose cross-link of adjacent polymer chains: atomic force microscopy and static molecular modelling.

Peter D Cooper1, K Harinda Rajapaksha2, Thomas G Barclay3, Milena Ginic-Markovic3, Andrea R Gerson3, Nikolai Petrovsky4.   

Abstract

Semi-crystalline microparticles of inulin (MPI) have clinical utility as potent human vaccine adjuvants but their relevant surface structure and crystal assembly remain undefined. We show inulin crystal surfaces to resemble multi-layered, discoid radial spherulites resulting from very rapid formation of complex tertiary structures, implying directed crystal initiation. Physical and in silico molecular modelling of unit cells confirm steric feasibility of initiation by hydrogen-bonded cross-linking of terminal glucose to a fructose of another chain, mimicking bonding in sucrose crystals. A strong, chelate-like dual H-bond is proposed to compel the known antiparallel alignment of inulin chains. Such cross-linking would require one extra fructose per chain in the native inulin crystal, as observed. Completion of five H-bonded internal ring-domains would 'lock in' each new 6-fructose structural unit of each antiparallel helix pair to create a new isoform. All known properties of inulin isoforms follow readily from these concepts.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adjuvant; Fructose (PubChem CID: 5984); Glucose (PubChem CID: 5793); Glycerol (PubChem CID: 753); Inulin from chicory (PubChem CID: 16219508); Isoform; Model; Structure; Sucrose (PubChem CID: 5988); Vaccine; l-Xylose (PubChem CID: 95259)

Mesh:

Substances:

Year:  2014        PMID: 25498723      PMCID: PMC4268547          DOI: 10.1016/j.carbpol.2014.10.022

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  12 in total

1.  Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses.

Authors:  Yoshikazu Honda-Okubo; Fadi Saade; Nikolai Petrovsky
Journal:  Vaccine       Date:  2012-06-20       Impact factor: 3.641

2.  Physicochemical studies on the biopolymer inulin: a critical evaluation of its self-aggregation, aggregate-morphology, interaction with water, and thermal stability.

Authors:  Abhijit Dan; Soumen Ghosh; Satya P Moulik
Journal:  Biopolymers       Date:  2009-09       Impact factor: 2.505

3.  The polysaccharide inulin is characterized by an extensive series of periodic isoforms with varying biological actions.

Authors:  Peter D Cooper; Thomas G Barclay; Milena Ginic-Markovic; Nikolai Petrovsky
Journal:  Glycobiology       Date:  2013-07-12       Impact factor: 4.313

4.  Single crystals of inulin.

Authors:  I André; J L Putaux; H Chanzy; F R Taravel; J W Timmermans; D de Wit
Journal:  Int J Biol Macromol       Date:  1996-04       Impact factor: 6.953

5.  Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant.

Authors:  David L Gordon; Dimitar Sajkov; Richard J Woodman; Yoshikazu Honda-Okubo; Manon M J Cox; Susanne Heinzel; Nikolai Petrovsky
Journal:  Vaccine       Date:  2012-06-17       Impact factor: 3.641

6.  Delta inulin: a novel, immunologically active, stable packing structure comprising β-D-[2 -> 1] poly(fructo-furanosyl) α-D-glucose polymers.

Authors:  Peter D Cooper; Nikolai Petrovsky
Journal:  Glycobiology       Date:  2010-12-07       Impact factor: 4.313

7.  JE-ADVAX vaccine protection against Japanese encephalitis virus mediated by memory B cells in the absence of CD8(+) T cells and pre-exposure neutralizing antibody.

Authors:  Maximilian Larena; Natalie A Prow; Roy A Hall; Nikolai Petrovsky; Mario Lobigs
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

8.  Inulin isoforms differ by repeated additions of one crystal unit cell.

Authors:  Peter D Cooper; Thomas G Barclay; Milena Ginic-Markovic; Andrea R Gerson; Nikolai Petrovsky
Journal:  Carbohydr Polym       Date:  2013-12-31       Impact factor: 9.381

9.  An inactivated cell culture Japanese encephalitis vaccine (JE-ADVAX) formulated with delta inulin adjuvant provides robust heterologous protection against West Nile encephalitis via cross-protective memory B cells and neutralizing antibody.

Authors:  Nikolai Petrovsky; Maximilian Larena; Venkatraman Siddharthan; Natalie A Prow; Roy A Hall; Mario Lobigs; John Morrey
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

10.  Gamma ray sterilization of delta inulin adjuvant particles (Advax™) makes minor, partly reversible structural changes without affecting adjuvant activity.

Authors:  P D Cooper; T G Barclay; M Ginic-Markovic; N Petrovsky
Journal:  Vaccine       Date:  2013-12-14       Impact factor: 3.641

View more
  5 in total

1.  Physical characterization and in silico modeling of inulin polymer conformation during vaccine adjuvant particle formation.

Authors:  Thomas G Barclay; Harinda Rajapaksha; Alagu Thilagam; Gujie Qian; Milena Ginic-Markovic; Peter D Cooper; Andrea Gerson; Nikolai Petrovsky
Journal:  Carbohydr Polym       Date:  2016-01-29       Impact factor: 9.381

2.  Randomized controlled trial demonstrating the benefits of delta inulin adjuvanted immunotherapy in patients with bee venom allergy.

Authors:  Robert Heddle; Anthony Smith; Richard Woodman; Pravin Hissaria; Nikolai Petrovsky
Journal:  J Allergy Clin Immunol       Date:  2019-07-09       Impact factor: 10.793

3.  Identification and characterisation of T-cell epitopes for incorporation into dendritic cell-delivered Listeria vaccines.

Authors:  Ricardo Calderon-Gonzalez; Raquel Tobes; Eduardo Pareja; Elisabet Frande-Cabanes; Nikolai Petrovsky; Carmen Alvarez-Dominguez
Journal:  J Immunol Methods       Date:  2015-05-29       Impact factor: 2.303

4.  Doxorubicin-Loaded Delta Inulin Conjugates for Controlled and Targeted Drug Delivery: Development, Characterization, and In Vitro Evaluation.

Authors:  Lixin Wang; Yunmei Song; Ankit Parikh; Paul Joyce; Rosa Chung; Liang Liu; Franklin Afinjuomo; John D Hayball; Nikolai Petrovsky; Thomas G Barclay; Sanjay Garg
Journal:  Pharmaceutics       Date:  2019-11-06       Impact factor: 6.321

Review 5.  Advax™, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety.

Authors:  Nikolai Petrovsky; Peter D Cooper
Journal:  Vaccine       Date:  2015-09-25       Impact factor: 3.641

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.